ArticleKidney medicine2026
McCune-Albright Syndrome as a Rare Cause of Fanconi Syndrome and Kidney Failure: A Case Report and Literature Review.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multidisciplinary approach and clinical management of McCune-Albright syndrome.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
McCune-Albright syndrome (MAS) is a rare systemic genetic condition classically characterized by childhood-onset polyostotic fibrous dysplasia, café-au-lait skin pigmentation, and precocious puberty. Kidney involvement in MAS is infrequently recognized, particularly in low- and middle-income countries where genomic testing may be limited. We presented the first case report of MAS presenting with Fanconi syndrome and progressive kidney failure, which we postulated represents a phenotypic expansion of the renal phenotype associated with MAS, in addition to hyperthyroidism, osteoid osteoma, bone marrow failure secondary to fibrous dysplasia, and congenital ovarian failure. Initial renal biochemical evaluations were suggestive of proximal tubulopathy; however, secondary investigations were inconclusive. Seventeen years after the patient's initial presentation, clinically accredited whole exome sequencing conducted under a national genomic research initiative identified a pathogenic
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.